Advertisement

Topics

Nature Cell Started Commercial Clinical Trials Phase I and II ‘ASTROSTEM,’ Stem Cell Drug for Alzheimer's Disease Treatment in U.S.

08:00 EST 10 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
- Started Recruitment of Patients at Two Hospitals in U.S. Biotechnology enterprise Nature Cell (KOSDAQ:007390) announced that it had started to recruit patients for its clinical trials of ‘ASTROSTEM,’ a stem cell drug f...

Other Sources for this Article

Biostar Stem Cell Research Institute
Hyerim Park, +82-2-874-0686 (Ext. 216)
herim16@stemcellbio.com

NEXT ARTICLE

More From BioPortfolio on "Nature Cell Started Commercial Clinical Trials Phase I and II ‘ASTROSTEM,’ Stem Cell Drug for Alzheimer's Disease Treatment in U.S."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...